Search research articles
Contact Us
Filters
Showing results (1-10 of 798) with videos related to
Page
of 80
Sort By:
Psychotherapy and Psychosomatics
|
August 19, 2007
The combination of buspirone and bupropion in the treatment of depression
Maurizio Fava
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
September 27, 2015
The role of regulators, investigators, and patient participants in the rise of the placebo response in major depressive disorder
Maurizio Fava
JAMA Psychiatry
|
October 1, 2015
Implications of a Biosignature Study of the Placebo Response in Major Depressive Disorder
Maurizio Fava
The Journal of Clinical Psychiatry
|
August 6, 2009
Partial responders to antidepressant treatment: switching strategies
Maurizio Fava
The Journal of Clinical Psychiatry
|
December 9, 2003
Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment
Maurizio Fava
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 26, 2023
How should we design future mechanistic and/or efficacy clinical trials?
Maurizio Fava
Biological Psychiatry
|
April 23, 2003
Diagnosis and definition of treatment-resistant depression
Maurizio Fava
The Journal of Clinical Psychiatry
|
May 21, 2003
Depression with physical symptoms: treating to remission
Maurizio Fava
The Journal of Clinical Psychiatry
|
December 4, 2004
Daytime sleepiness and insomnia as correlates of depression
Maurizio Fava
The Journal of Clinical Psychiatry
|
October 14, 2003
The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression
Maurizio Fava
Page
of 80
Search research articles
Search
Showing results (1-10 of 798) with videos related to
Sort By:
Page
of 80
Psychotherapy and Psychosomatics
|
August 19, 2007
The combination of buspirone and bupropion in the treatment of depression
Maurizio Fava
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
September 27, 2015
The role of regulators, investigators, and patient participants in the rise of the placebo response in major depressive disorder
Maurizio Fava
JAMA Psychiatry
|
October 1, 2015
Implications of a Biosignature Study of the Placebo Response in Major Depressive Disorder
Maurizio Fava
The Journal of Clinical Psychiatry
|
August 6, 2009
Partial responders to antidepressant treatment: switching strategies
Maurizio Fava
The Journal of Clinical Psychiatry
|
December 9, 2003
Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment
Maurizio Fava
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 26, 2023
How should we design future mechanistic and/or efficacy clinical trials?
Maurizio Fava
Biological Psychiatry
|
April 23, 2003
Diagnosis and definition of treatment-resistant depression
Maurizio Fava
The Journal of Clinical Psychiatry
|
May 21, 2003
Depression with physical symptoms: treating to remission
Maurizio Fava
The Journal of Clinical Psychiatry
|
December 4, 2004
Daytime sleepiness and insomnia as correlates of depression
Maurizio Fava
The Journal of Clinical Psychiatry
|
October 14, 2003
The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression
Maurizio Fava
Page
of 80